Skip to content

600436.SH

片仔癀

SSE · Healthcare · Drug Manufacturers - General · CN

CNY 123.76
−0.27%
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue8.6B9.0B10.8B10.1B8.7B
Cost of Revenue5.6B5.7B6.2B5.4B4.7B
Gross Profit3.0B3.3B4.6B4.7B4.0B
Operating Expenses
R&D Expense268.9M252.2M269.6M232.4M230.0M
SG&A Expense
General & Admin Expense375.3M359.2M340.5M367.0M331.0M
Selling & Marketing Expense435.1M401.0M517.6M782.8M483.4M
Other Expenses
Total Operating Expenses1.2B1.1B1.2B1.5B1.1B
Cost and Expenses6.7B6.8B7.4B6.8B5.8B
Operating Income (EBIT)2.2B2.5B3.6B3.4B3.0B
Non-Operating
Interest Income
Interest Expense
Net Interest Income
Other Non-Op Income/Expense
Non-Operating Income (excl Interest)
EBT (Pre-Tax Income)2.2B2.5B3.5B3.4B3.0B
Income Tax Expense361.3M394.5M543.2M517.8M454.8M
Bottom Line
Net Income1.9B2.2B3.0B2.8B2.5B
Earnings from Cont. Ops1.9B2.1B3.0B2.9B2.5B
Earnings from Discont. Ops
Bottom Line Net Income1.9B2.2B3.0B2.8B2.5B
Per Share
Basic EPSCN¥3.15CN¥3.58CN¥4.93CN¥4.64CN¥4.10
Diluted EPSCN¥3.15CN¥3.58CN¥4.93CN¥4.64CN¥4.10
Revenue Per ShareCN¥14.23CN¥14.93CN¥17.87CN¥16.68CN¥14.42
Shares
Basic Shares Outstanding604.5M603.0M603.9M602.9M603.0M
Diluted Shares Outstanding604.5M603.0M603.9M602.9M603.0M
Profitability Metrics
EBITDA2.6B3.6B3.5B3.0B
D&A88.5M64.9M94.1M62.7M
EBIT

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026